Scholarlink

Within the field of pediatric preventive medicine, there are children who fall outside the realm of primordial prevention. These populations have established cardiovascular (CV) risk factors related to a variety of underlying medical diagnoses, including genetic conditions, that place them into the category of primary prevention. The presence of these conditions from a young age contributes to a high lifetime risk of ASCVD. Preventive treatment in these populations aims to treat the CV risk factor, thereby decreasing its subsequent morbidity and mortality later in life.

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Pharmacologic Therapy to Prevent CV Disease in High-Risk Youth

  • 章节

  • 发表日期：

    2026年

查看全文
  • Jacob Hartz,
  • Michelle Degen,
  • Adam Ware

摘要

Within the field of pediatric preventive medicine, there are children who fall outside the realm of primordial prevention. These populations have established cardiovascular (CV) risk factors related to a variety of underlying medical diagnoses, including genetic conditions, that place them into the category of primary prevention. The presence of these conditions from a young age contributes to a high lifetime risk of ASCVD. Preventive treatment in these populations aims to treat the CV risk factor, thereby decreasing its subsequent morbidity and mortality later in life.